In adult men, Proscar is used to decrease an enlarged prostate (also known as benign prostatic hyperplasia or BPH). It can be used alone or in combination with other medications to alleviate BPH symptoms and possibly avoid surgery. Proscar (Finasteride) may help with BPH symptoms by reducing the need to urinate, improving urine flow with less straining, reducing the sense that the bladder isn't empty, and reducing overnight urination.
This medication works by lowering the quantity of DHT, a natural body hormone that drives prostate growth. Proscar isn't approved for prostate cancer prevention. It may raise the risk of acquiring a very dangerous form of prostate cancer by a small amount.
Keep a list of everything you use (including prescription and non-prescription pharmaceuticals, as well as herbal products) and discuss it with your doctor and pharmacist. Without your doctor's permission, do not begin, stop, or modify the dosage of any medications. The findings of a blood test used to identify prostate cancer may be influenced by this medicine (prostatic-specific antigen or PSA levels).
Proscar works by relaxing the blood vessels in the penis, allowing for increased blood flow, and reducing the urge to urinate. It does not affect blood pressure or speed sexual performance. It does not interfere with sexual development or drive you to start or change the way you get or keep an erection.What is this medicine used to treat?
Proscar is used to treatbreast cancer in womenwho have been diagnosed with early breast cancer, or who have not yet had cancer in the past 2 years. It is also used to treatmale pattern hair lossandovulation problems.
How should I use this medicine?
Proscar is amale sex hormone receptorreceptor (SHTR) inhibitor that may be usedto treatbreast cancer and male pattern hair loss.
This medicine may be used alone or in combination with other medicines as directed by your doctor.
This medicine may be takenas neededonly on an empty stomach.If you have a stomach ulcer, contact your doctor immediately or go to the Emergency Department at the nearest hospital.
What happens if I miss a dose?
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
This medicine may be used
receptor inhibitor that may be used
General:Patients with large residual urine volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy.Effects on PSA and Prostate Cancer Detection:No clinical benefit has yet been demonstrated in patients with prostate cancer treated with cystoduodenal native proscarLESS. However, a small number of men (mean age was known to be stable on initial data from a prostatic cancer treatment) have had successful prostate cancer screening during follow-up. No major adverse events have been reported with native proscarLESS treatment. In patients with prostatic cancer, prostate volume, clinical condition, and disease-free survival from prostate cancer treatment are likely to be similar to those seen in healthy subjects. There is no specific cure or target, but agents with established benefit in prostate cancer patients may be considered for treatment in appropriate cisities.
Special Precautions:
Pregnancy:Use only under strict medical supervision. Do not use in animals or in any way influenced byeaturing to human use. The safety of such useis generally unknown in humans. ProscarLESS has been associated with an increased risk of thrombotic events and meibomian gland enlargement and toxic epidermal necrolysis. Inhibition of prostatitisirty has been associated with an increased riskof increased incidence of prostate cancer. Patients with a history of myasthenia gravis should be advised to refrain from using ProscarLESS, as this combinationmay exacerbate meibomian gland enlargement and toxic epidermal necrolysis. Patients with a known tendency to myasthenia gravis should be advised to refrain from using ProscarLESS, as this combinationmay exacerbate meibomian gland enlargement and toxic epidermal necrolysis. ProscarLESS has been associated with an increased riskof increased incidenceof thrombotic events and meibomian gland enlargement and toxic epidermal necrolysis. ProscarLESS has beenassociated with an increased riskof thrombotic events and meibomian gland enlargement and toxic epidermal necrolysis. ProscarLESS has beenassociated with an increased riskof thrombotic events and meibomian gland enlargementand toxic epidermal necrolysis. ProscarLESS has beenassociated with an increased risk of thrombotic events and meibomian gland enlargementand toxic epidermal necrolysis.
May be taken with or without food.
Hypersensitivity, including asthma, bronchitis, eosinophilia, and systemic lupus erythematosus. Adverse events include anticholinergic effects, myophilia, and dermatologic reactions. Discontinue if adverse effect occurs. Discontinue if allergic reactions occur. Discontinue without a physician's prescription if prostate cancer has already occurred. Prostate cancer may recur after initial therapy. Patients with known hypersensitivity to cystoduodenal native proscarLESS are not at increased risk for this adverse reaction. Patients with significant residual urine volume are at greater risk for this adverse reaction. Patients with severe abdominal distress or urinary incontinence are at greater risk for this adverse reaction. Patients with severe hepatic impairment are at greater risk for this adverse reaction. Patients with anuria or other abnormally prolonged urination are at greater risk for this adverse reaction. Patients with a history of prostate cancer are at greater risk for this adverse reaction. Renal impairment may cause this adverse reaction. Patients with a history of myasthenia gravis are at greater risk for this adverse reaction.
Chloramphenicol
The use of this drug is contraindicated because the use of chloramphenicol will increase the effect of Sildenafil by affecting the patient hepatic and intestinal enzyme metabolism.
Isosorbide dinitrate
The use of this drug is contraindicated because the combination of this drug either increases the effects of the other by vasodilation which leads to fatal hypotension.
Nitroprusside sodium
The use of this drug is contraindicated because the combination of this drug either increases the effects of the others by pharmacodynamic synergism.
Enzalutamide
Use alternative drugs because the use of enzalutamide will decrease the effect of Sildenafil by affecting patient hepatic and intestinal enzyme metabolism.
Acetazolamide
Therapy should be administered with caution because the use of Sildenafil increases the effect of acetazolamide by pharmacodynamic synergism and it also increases the risk of hypotension.
The use of this medicine can lower blood pressure and when combining it with alcohol further increases the effect. You may experience dizziness, lightheadedness, fainting, flushing, headache, and heart palpitation. Also, avoid consuming grapefruit juice because it may increase the effect of avanafil on blood levels.
Cardiovascular disease:
The use of phosphodiesterase-5 enzyme inhibitors is contraindicated in patients with cardiovascular disease. A doctor should consider the vasodilatory effects of this drug and whether they may affect patients with cardiovascular disease. The use of this drug may increase the risk of angina pectoris, AV block, myocardial infarction, ventricular arrhythmia, tachycardia, palpitation, hypotension, postural hypotension, syncope, cerebral thrombosis, cerebrovascular hemorrhage, transient ischemic attack, cardiac arrest, heart failure, and hypertension. These events can occur during or after sexual activity.
Renal dysfunction:
Therapy should be administered with caution in patients with severe renal disease or on renal dialysis. The plasma clearance of this drug is decreased in patients with a severe renal impairment which results in drug accumulation.
Liver diseases:
The use of this drug is not recommended for patients with severe hepatic impairment because the pharmacokinetic disposition of this drug has not been assessed in patients with severe hepatic impairment.
undrumasonerThe use of this medicine can reduce the absorption of açolol by some people, this medicine may reduce the effect of avanafil because the pharmacodynamics of this drug have not been evaluated in patients with patients with patients with severe renal impairment who are taking on onychomycosis.
You can get online prescription for this drug for free in Pakistan from local pharmacy. You can pay no extra by using the form in which you have obtained original prescription.
A doctor should consider the vasodilatory effects of this drug and whether they may increase the risk of angina pectoris, AV block, myocardial infarction, ventricular arrhythmia, tachycardia, shivering, heat shock, postural hypotension, cerebral thrombosis, cerebrovascular hemorrhage, transient ischemic attack, cardiac arrest, and hypertension.
The pharmacokinetic disposition of this drug is not affected by renal impairment which results in acetazolamide accumulation.